ArticleTurkish journal of anaesthesiology and reanimation2025
Comparison of EuroSCORE II and STS Risk Scoring Systems in Patients who Underwent Open-heart Surgery.
Article in Turkish journal of anaesthesiology and reanimation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Comparative Predictive Performance of EuroSCORE II and the STS Score for Postoperative Cardiopulmonary Complications in Older Adults Undergoing Cardiac Surgery.Journal of clinical medicine · 2026Article
- Beyond EuroSCORE II: is artificial intelligence ready to redefine risk stratification in cardiothoracic surgery?Annals of medicine and surgery (2012) · 2026Article
- Risk Stratification for Postoperative Mortality in Cardiac Surgery: "Quo Vadis"?Medicina (Kaunas, Lithuania) · 2026Review
- Twin Transformation in Cardiothoracic Surgery: The Convergence of Digital Innovation and Sustainability.Journal of cardiovascular development and disease · 2026Review
- Cost Implications and Perspectives of TAVI versus SAVR in the Hospital Setting.Arquivos brasileiros de cardiologia · 2025Article
- Hematological Inflammatory Gradient Score (HIGS): A Novel Predictor of Early Mortality After Coronary Artery Bypass Grafting.Journal of inflammation research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In the present study, European Cardiac Operative Risk Assessment System II (EuroSCORE II) and the Society of Thoracic Surgery (STS) risk scoring systems were used to predict mortality in patients who underwent various types of open-heart surgery, including coronary artery bypass grafting, aortic valve replacement, mitral valve replacement, and combined valve surgery with coronary artery bypass grafting, in the cardiovascular surgery operating room. The aim was to compare risk assessment systems regarding their clinical applicability. Methods: A total of 469 patients, 141 (30.1%) female and 328 (69.9%) male, were included in the study. All risk factors were retrospectively recorded according to the EuroSCORE II and STS risk assessment systems. Statistical analysis was performed using the receiver operating characteristic (ROC) curve. Predicted and actual mortality rates were compared for each risk-scoring system. Results: When the ability of the EuroSCORE and STS risk classifications to predict mortality was analyzed using the ROC curve, the area under the curve for the EuroSCORE II risk score was 78.3% ( Conclusion: In our study, the STS risk scoring system was found to be more accurate in predicting in-hospital mortality than the EuroSCORE. However, there was no statistically significant difference between the expected and observed mortality rates in either risk-scoring system. There is no consensus in the literature regarding which scoring system is more effective. More studies from different societies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.